Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytel and Searle to collaborate on cancer therapies

Sep. 15, 1997

Oncologic Drugs Advisory Committee meets this week

Sep. 15, 1997

Matrix discontinues U.S. development of AccuSite

Sep. 15, 1997

Biricodar dicitrate enters phase II studies in ovarian cancer

Sep. 12, 1997

Clinical studies begin with BNP-7787

Sep. 12, 1997

Final phase I/IIa data reported on oral Panretin in APL

Sep. 11, 1997

Letrozole approved in Canada

Sep. 10, 1997

Heat treatment for liver cancer assessed in clinical trials

Sep. 10, 1997

Another Isis oligonucleotide enters clinical testing

Sep. 10, 1997

Bexxar now administered on outpatient basis

Sep. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...